Current research is focused on understanding the mechanistic pathways that lead to NFT formation and identifying potential biomarkers for early diagnosis. There is also significant interest in developing therapeutic strategies to degrade or prevent tau aggregates. For example, immunotherapies targeting tau, small molecules that inhibit tau phosphorylation, and proteostasis regulators are under investigation.
